Showing 2561-2570 of 2652 results for "".
- Ocular Therapeutix Announces Completion of Debt Refinancinghttps://modernod.com/news/ocular-therapeutix-announces-completion-of-debt-refinancing/2476236/Ocular Therapeutix announced that it has closed a refinancing of its existing debt by entering into a new $25 million term loan with MidCap Financial and Silicon Valley Bank. The 5-year term loan facility allows for an expansion of the company’s prior $18 million credit facility to $25 mil
- Kodiak Sciences Announces Completion of 12-Week Phase 1a Study of KSI-301 in Patients with DMEhttps://modernod.com/news/kodiak-sciences-announces-completion-of-12-week-phase-1a-study-of-ksi-301-in-patients-with-diabetic-macular-edema/2476243/Kodiak Sciences reported 12-week data from its phase 1a single ascending dose clinical study of KSI-301, an investigational anti-VEGF antibody biopolymer conjugate, in nine patients with severe diabetic macular edema. After a single dose, eight of nine patients responded to KSI-301, as ass
- Market Scope: Global Dry Eye Products Market to Total $6.2 Billion in 2023https://modernod.com/news/market-scope-global-dry-eye-products-market-to-total-6-2-billion-in-2023/2476251/Providers of dry eye therapies can expect to see healthy growth in revenues overall in the next five years as people suffering from dry eye increasingly seek treatment. Market Scope looks for manufacturers’ global revenues in the dry eye treatments market to climb from $4.6 billion in 2018
- The Number of Optometric Practices Offering neurolens Contoured Prism Lenses More Than Quadrupled in 2018https://modernod.com/news/the-number-of-optometric-practices-offering-neurolens-contoured-prism-lenses-more-than-quadrupled-in-2018/2479617/Costa Mesa, California-based neurolens announced that adoption of their prescription lenses has grown among US optometric (OD) practices and by year end, 31 states will carry the company’s neurolenses and the neurolens measurement device. neurolenses are the first and only prescripti
- Federal Trade Commission Penalizes Online Sellers for Violating Contact Lens Rule, Bans Them from Selling Lenses in Futurehttps://modernod.com/news/federal-trade-commission-penalizes-online-sellers-for-violating-contact-lens-rule-bans-them-from-selling-lenses-in-future/2476152/The Healthcare Alliance for Patient Safety released a statement following yesterday’s announcement from the Federal Trade Commission (FTC)
- Glaucoma-Staging Systems May Underestimate Severityhttps://modernod.com/news/glaucoma-staging-systems-may-underestimate-severity/2479639/Standard automated perimetry (SAP) testing is often used to classify glaucoma severity but may fail to detect macular damage, according to New York City-based researchers, as reported in Reuters. “Because current staging syst
- FDA Approves Genentech’s ACTPen, the Actemra Autoinjector, for Giant Cell Arteritis, Other Indicationshttps://modernod.com/news/fda-approves-genentechs-actpen-the-actemra-autoinjector-for-giant-cell-arteritis-other-indications/2479647/Genentech announced that the FDA has approved ACTPen 162 mg/0.9 mL, a single-dose prefilled autoinjector for Actemra (tocilizumab), as an additional formulation for adult patients with moderate to severe active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-m
- Recipients of the 2018 OWL Awards Recognized for Advancing Diversity in Ophthalmology Leadershiphttps://modernod.com/news/recipients-of-the-2018-owl-awards-recognized-for-advancing-diversity-in-ophthalmology-leadership/2479662/OWL: Advancing Diversity in Leadership (OWL) announced the winners of the 2018 OWL Awards at the organization’s Signature Event, which was held October 28 in Chicago during the annual meeting of the American Academy of Ophthalmology (AAO 2018). OWL presents the awards each year to those who best
- Eyepatch With Dissolvable Needles Used to Treat Eye Diseasehttps://modernod.com/news/eyepatch-with-dissolvable-needles-used-to-treat-eye-disease/2479667/A team of researchers affiliated with several institutions in Singapore has developed an eyepatch with dissolvable needles for use in treating eye diseases, according to a report in Medical Xpress.
- New Melanoma Treatments Do Not Supplant Surgery as First-Line Therapyhttps://modernod.com/news/new-melanoma-treatments-do-not-supplant-surgery-as-first-line-therapy/2479670/Although several new melanoma treatments have shown promise, none replaces surgery as the primary therapy yet, according to updated guidelines from the American Academy of Dermatology (AAD), as reported in Reuters Health. “Su